A propos de votre organisation

BiomimX is a pioneer in the generation of advanced predictive models of human organs and pathologies that will revolutionize the way to test drugs.

BiomimX mission is to bring native-like movement (“beating”) into in vitro preclinical models, to mimic human pathophysiology with an unprecedented level of precision. Towards this mission, BiomimX dissects human tissues motion states to unlock a new generation of dynamic preclinical models with unprecedented clinical relevance, leading to more reliable, fast responsive and affordable pre-clinical models for drug screening and disease modeling applications.

Building on its deep-techs, uBeat® and uSense, BiomimX thus overcomes current OoC limitations, proposing the first OoC enabling to mimic a wide range of organs and pathologies and to test toxicity/efficacy/functionality of drugs/medical devices/advanced therapies with unprecedented precision by real-time monitoring of clinically relevant parameters from such in-vitro twins”.

Born as a deep-tech company in 2017, spinoff of Politecnico di Milano, BiomimX is today projected towards the future, envisioning a scenario in which animal models will not be considered representative anymore of human response to medical products, while drugs will be immediately tested on “in vitro twins” of patients, towards a precision medicine approach.

Actualités

Réseau (0)

Il n'y a pas encore d'organisations dans le réseau.

Activité récente

Vous n'êtes pas connecté(e)

Un certain nombre de contenus vous sont cachés et vous ne bénéficiez pas des fonctionnalités de mises en relation.

Log in or register pour accéder à l’intégralité des contenus et fonctionnalités d’EuroQuity : l’inscription est rapide et gratuite !